TERT promoter mutations were frequent in the BRAF, RAS, and NF1 subtypes (ranging from 72% to 83%), while they are rare in Triple-WT (about 7%); in this last tumor subtype, alternative mechanisms (gene amplification) are involved in TERT activation [86]. The gene discussed is BRAF; the disease is neoplasm.